Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
Schiller
GLOBETECH PUBLISHING LLC

New “Bank” Adds Genomics Service to Patient Care

By HospiMedica International staff writers
Posted on 07 Mar 2013
A new company is offering a “gene vault” service for doctors who need a better way to store, protect, and share genomic data.

Coriell Life Sciences (Camden, NJ, USA), a startup company that grew out of a partnership between the Coriell Institute for Medical Research (Camden, NJ, USA) and IBM (Armonk, NY, USA) is offering a service to facilitate sequencing a patient’s DNA—through existing sequencing companies such as Illumina (San Diego, CA, USA) or Ion Torrent—and store it in its so-called gene vault, and also act as the middleman between doctors and companies that offer interpretation services.

The cloud-based workflow could help doctors in different locations take advantage of expert interpretations anywhere, analyzing a patient’s genome for DNA variants linked to poor drug response at one point, and later on, for example, order another for variants linked to heart disease. The company will also use a board of scientific advisors to guide them as to the best interpretation programs available. Since keeping the genomic data secure is a key component of the venture, the data will be stored at IBM headquarters and would be available only to limited users. If a patient changes a health-care provider, the data will remain available for the next physician.

“The intent is that the doctor would order a test like any other diagnostic test they order today,” said Scott Megill, president of Coriell Life Sciences. “We will return the genetic result in the human readable form back to the electronic medical record so the doctor can read it and interpret it for the patient.”

“No one company is in position to interpret the entire genome for its meaning,” said Michael Christman, CEO of the Coriell Institute for Medical Research. “But by having one’s sequence in the gene vault, then the physician will be able to order interpretative engines, analogous to apps for the iPhone.”

Whole genome sequencing is a laboratory process that determines the complete DNA sequence of an organism's genome at a single time. Almost any biological sample containing a full copy of the DNA can provide the material necessary for full genome sequencing. Such samples may include saliva, epithelial cells, bone marrow, or anything else that has DNA-containing cells. Because the sequence data that is produced can be quite large (for example, there are approximately six billion base pairs in each human diploid genome), genomic data is stored electronically and requires a large amount of computing power and storage capacity.

Related Links:

Coriell Institute for Medical Research
IBM
Illumina




Inditherm
Harloff
JD Honigberg International

Channels

Surgical Techniques

view channel

Thinner Minilaparoscopic Instruments Ease Procedural Tasks

A new study that examined surgeons’ perceptions of transanal endoscopic microsurgery (TEM) using minilaparoscopic instruments reveals that thinner is better. Researchers at the University of Sao Paulo (USP; Brazil), the Federal University of Pernambuco (Recife, Brazil), and other institutions hypothesized that visualization... Read more

Women's Health

view channel
Image: The Bloom Ring fertility app monitoring core temperature (Photo courtesy of Prima-Temp).

Subtle Temperature Sensor Heightens Fertility Awareness

A new self-inserted core temperature sensor helps women detect when a fertility “window of opportunity” opens. The Bloom Ring is a core body temperature fertility sensor that is inserted by the user... Read more

Hospital News

view channel
Image: The new Parkland Memorial Hospital (Photo courtesy of Parkland Memorial Hospital).

New Parkland Memorial Hospital Nears Completion

At nearly twice the size of the current hospital, the new Parkland Memorial Hospital (Dallas, TX, USA) will be one of the first “digital hospitals” in the United States. The new hospital, built at... Read more

Business

view channel

Moderate Growth Expected for Global Medical Device Market

While the global market for medical devices reached an estimated USD 361 billion in 2014, the average growth was only 3%. These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm. The growth was driven by countries outside of the traditional markets that include... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.